State of Wisconsin Investment Board’s Ascendis Pharma A/S ASND Stock Holding History

State of Wisconsin Investment Board’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,055	Closed	-$1.88M	–	2514
2023 Q2	$1.88M	Buy	21,055 +6,361	+43%	+$554K	0.01%	1307
2023 Q1	$1.58M	Sell	14,694 -633	-4%	-$72.4K	﹤0.01%	1362
2022 Q4	$1.87M	Sell	15,327 -541	-3%	-$62.8K	0.01%	1336
2022 Q3	$1.64M	Sell	15,868 -3,720	-19%	-$353K	0.01%	1388
2022 Q2	$1.82M	Sell	19,588 -7,900	-29%	-$745K	﹤0.01%	1394
2022 Q1	$3.23M	Buy	27,488 +3,435	+14%	+$398K	0.01%	1329
2021 Q4	$3.24M	Hold	24,053	–	–	0.01%	1156
2021 Q3	$3.83M	Hold	24,053	–	–	0.01%	1115
2021 Q2	$3.16M	Buy	24,053 +3,407	+17%	+$454K	0.01%	1178
2021 Q1	$2.66M	Sell	20,646 -3,520	-15%	-$535K	0.01%	1175
2020 Q4	$4.03M	Buy	24,166 +5,866	+32%	+$970K	0.01%	1056
2020 Q3	$2.82M	Buy	+18,300	New	+$2.63M	0.01%	1098

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State of Wisconsin Investment Board's ASND Position: Q3 2023 in Review

State of Wisconsin Investment Board sold out of Ascendis Pharma A/S (ASND) in Q3 2023, closing a stake of 21,055 shares — an estimated $1.88M sold.

State of Wisconsin Investment Board first reported a position in ASND in Q3 2020 and held it in 12 quarters. The position peaked at $4.03M in Q4 2020. 160 funds tracked by Wall St. Rank hold ASND as of Q3 2023.

State of Wisconsin Investment Board reported no remaining Ascendis Pharma A/S position as of Q3 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 21,055 Ascendis Pharma A/S shares in Q3 2023, an estimated $1.88M.
State of Wisconsin Investment Board first reported a position in Ascendis Pharma A/S in Q3 2020 and held it in 12 quarters.
State of Wisconsin Investment Board's Ascendis Pharma A/S position peaked at $4.03M in Q4 2020.
160 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2023, filed 14 Nov 2023.